a Two major issues which hamper the use of the anticancer drug cisplatin are the development of cancer cell resistance and its nephrotoxicity. One possible mechanism by which resistance is reported to develop is a reduction in drug uptake across the cell membrane. While the passive uptake of cisplatin has long been cited as an important contribution, far greater attention has been given to active modes of uptake, particularly in recent research. Using unilamellar lipid vesicles together with the stopped-flow kinetic method we show here that the permeability coefficient of cisplatin increases significantly with the chloride concentration of the medium. This supports the hypothesis that cisplatin can enter cells via passive permeation through the lipid phase of the membrane, but becomes trapped within the cytoplasm because dissociation of chloride ligands yields a membrane-impermeant positively-charged aqua derivative. This is important evidence for a major role of passive membrane diffusion in the uptake of cisplatin, and suggests that reduced cell uptake is unlikely to be a significant mechanism leading to the development of drug resistance. Studies of rubidium ion uptake into the cytoplasm of Xenopus oocytes via the Na
Regulation of the ion pumping activity of the Na+,K+-ATPase is crucial to the survival of animal cells. Recent evidence has suggested that the activity of the enzyme could be controlled by glutathionylation of cysteine residue 45 of the β-subunit. Crystal structures so far available indicate that this cysteine is in a transmembrane domain of the protein. Here we have analysed via fluorescence and NMR spectroscopy as well as molecular dynamics simulations whether glutathione is able to penetrate into the interior of a lipid membrane. No evidence for any penetration of glutathione into the membrane was found. Therefore, the most likely mechanism whereby the cysteine residue could become glutathionylated is via a loosening of the α-β subunit association, creating a hydrophilic passageway between them to allow access of glutathione to the cysteine residue. By such a mechanism, glutathionylation of the protein would be expected to anchor the modified cysteine residue in a hydrophilic environment, inhibiting further motion of the β-subunit during the enzyme's catalytic cycle and suppressing enzymatic activity, as has been experimentally observed. The results obtained, therefore, suggest a possible structural mechanism of how the Na+,K+-ATPase could be regulated by glutathione.
The oxidation of cis-diaquabis (1,10-phenanthroline) chromium(III) [cisCr III (phen) 2 (H 2 O) 2 ] 3+ by N -bromosuccinimide (NBS) to yield cis-dioxobis(1,10-phenanthroline)chromium(V) has been studied spectrophotometrically in the pH 1.57-3.56 and 5.68-6.68 ranges at 25.0°C. The reaction displayed biphasic kinetics at pH < 4.0 and a simple first order at the pH > 5.0. In the low pH range, the reaction proceeds by two successive steps; the first faster step corresponds to the oxidation of Cr(III) to Cr(IV), and the second slower one corresponds to the oxidation of Cr(IV) to Cr(V), the final product of the reaction. The formation of both Cr(IV) and Cr(V) has been detected by electron spin resonance (ESR). The ESR clearly showed the formation and decay of Cr(IV) as well as the formation of Cr(V). Each oxidation process exhibited a first-order dependence on the initial [Cr(III)]. The pseudo-first-order rate constants k 34 and k 45 , for the faster and slower steps, respectively, were obtained by a computer program using Origin7.0. Both rate constants showed first-order dependence on [NBS] and increased with increasing pH.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.